G

Gemini Therapeutics

34 employees

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology

Biopharma

Health Diagnostics

Date founded

2015

FAQ